All In MedTech

FDA Clearance Tracker · P210032-S015

GORE TAG Thoracic Branch Endoprosthesis (TBE Device)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 11, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 11, 2025

Approved

Time to decision

228 days

Received Aug 26, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P210032-S015
Device name
GORE TAG Thoracic Branch Endoprosthesis (TBE Device)
Applicant location
Flagstaff, AZ
Received
Aug 26, 2024
Decided
Apr 11, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P210032

Device type

Device class
Class III

Every decision under product code SDZ

FDA's approval statement

As written in FDA's record.

Approval for the GORE TAG Thoracic Branch Endoprosthesis (TBE Device) for expanding the indications to include treatment of lesions of the aortic arch. This device is indicated for endovascular repair of lesions of the aortic arch and descending thoracic aorta, while maintaining flow into a single aortic arch branch vessel, in patients with appropriate anatomy.

Source documents

Other decisions for W. L. Gore & Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.